LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences

NANot yet recruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

January 30, 2027

Study Completion Date

November 30, 2027

Conditions
Type 2 Diabetes Mellitus in ObeseType 2 Diabetes
Interventions
COMBINATION_PRODUCT

Low-Calorie Medicine Diet

Low-Calorie Medicine Diet meals which are 815-835 kcal/day (approximately 43% carbohydrate, 29% protein, and 29% fat), combined with physical activity.

COMBINATION_PRODUCT

Low-Calorie Diet

Low-Calorie Diet meals which are 815-835 kcal/day (approximately 43% carbohydrate, 29% protein, and 29% fat), combined with physical activity.

Trial Locations (1)

200074

Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Municipal Hospital of Traditional Chinese Medicine

OTHER

NCT06442150 - LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences | Biotech Hunter | Biotech Hunter